We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Guidance Gives Recommendations on Reconstituting Blood Products
FDA Guidance Gives Recommendations on Reconstituting Blood Products
January 16, 2007
The FDA issued a draft guidance with recommendations on how blood product manufacturers can apply for licenses to use placental or umbilical cord blood for treatments for hematological malignancies.